By contrast, an in vitro migration assay showed that gastric cancer cells with DAP3 downregulation presented a more invasive phenotype, which was consistent with the results of DAP3 expression analysis in a clinical gastric cancer cohort: lower DAP3 expression in patients who presented higher local recurrence and/or distant metastases (19). Here, DAP3 is linked to gastric cancer.